Skip to main content
Clinical Trials/IRCT2014011213739N2
IRCT2014011213739N2
Completed
Phase 1

A randomized controlled trial comparing the effects of ß-D-Mannuronic acid and immunosuppressive drugs on disease activity and inflammatory markers in patients with Rheumatoid Arthritis

Vice-Chancellor for Research, Tehran University of Medical Sciences0 sites35 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Rheumatoid Arthritis.
Sponsor
Vice-Chancellor for Research, Tehran University of Medical Sciences
Enrollment
35
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice-Chancellor for Research, Tehran University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: 25\-60 years old patients diagnosed with RA according to American College of Rheumatology Diagnostic Criteria after the initial visit by a specialist in rheumatology and parameters ESR, RF, CRP and Anti\-CCP elected. Also each patient must sign written informed consent.

Exclusion Criteria

  • History of fever and infectious diseases, positive pregnancy test or lactation, other collagen\- vascular diseases, other auto\-immune diseases, malignancies, patients have enrolled another Clinical Trial study within last 4 weeks, other concomitant diseases (Hepatic, renal, haematological, gastrointestinal, endocrine, cardiovascular, pulmonary, neurological or cerebral disease)

Outcomes

Primary Outcomes

Not specified

Similar Trials